Forecasts KROS (NASDAQ) - Keros Therapeutics Inc

In a future Version of ValueRay, a Subscription will be needed to see this page.

Earnings per Share Estimates vs Actual

Earnings per Share (Estimate and Actual). Can be non-GAAP or GAAP EPS.
EPS Stability:
-42.86%
EPS CGR:
9.47%

Revenue Estimates vs Actual

Revenue (Estimate and Actual)
Revenue Stability
-46.36%
Revenue CGR:
0%